T1	intervention 10 19	melatonin
T3	location 747 766	Copenhagen, Denmark
T4	age 775 786	30-75 years
T6	control 965 972	placebo
T7	outcome-Measure 1015 1047	incidence of depressive symptoms
T8	outcome-Measure 1093 1149	area under the curve (AUC) for the subjective parameters
T9	total-participants 1151 1153	54
T10	intervention-participants 1197 1199	28
T11	control-participants 1217 1219	26
T12	outcome 1309 1347	risk of developing depressive symptoms
T13	iv-bin-abs 1406 1407	3
T14	iv-bin-percent 1409 1413	11 %
T15	intervention-participants 1418 1420	27
T16	cv-bin-abs 1425 1426	9
T17	cv-bin-percent 1428 1432	45 %
T18	control-participants 1437 1439	20
T2	condition 23 54	depressive symptoms and anxiety
T5	eligibility 424 448	women with breast cancer
